Safety asssessment of iopromide contrast media: a narrative review focusing on adverse events
Curr Issues Pharm Med Sci., Vol. 36, No. 3, 163-167
João José Joaquim1,2*
, Cristiano Matos1, Ramona Mateos-Campos3
1 Pharmacy, Polytechnic Institute of Coimbra, Coimbra Health School, Portugal
2 Pharmacy, Universidad de Salamanca, Spain
3 Preventive Medicine and Public Health, Universidad de Salamanca, Spain
10.2478/cipms-2023-0028
© 2023 Author(s). This is an open access article distributed under the Creative Commons Attribution-NonComercial-No Derivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/)
Abstract
Many clinical contexts require radiological exams based on contrast media administration. Iodinated contrast media (ICM) represents one of the most studied contrast agents often used in radiological examinations. ICM vary widely in their physicochemical properties, clinical uses, as well as in the incidence of adverse reactions (ARs). Therefore, a basic understanding of ARs occurrence, risk factors, clinical features, and management of ICM is increasingly important in clinical practice. Iopromide is a nonionic ICM widely used in clinical practice due to its favourable safety profile and numerous applications. This narrative review provides a comprehensive report of the available data concerning iopromide ARs. It also analyses iopromide ARs occurrence and frequency with diverse potential risk factors such as age, sex and pre-existing conditions.
Full Text
Keywords
iodinated contrast media, iopromide, adverse reactions, safety, risk factors.
References
- Chen Z-Y, Wang Y-X, Lin Y, Zhang J-S, Yang F, Zhou Q-L, et al. Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. BioMed Res Int. 2014;2014:819324.
- Ganguly D, Chakraborty S, Balitanas M, Kin T-H. Medical imaging: A review. In: Security-Enriched Urban Computing and Smart Grid. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010.
- Hussain S, Mubeen J, Ullah N, Shah SS, Khan BA, Zahoor M, et al. Modern diagnostic imaging technique applications and risk factors in the medical field: A review. BioMed Res Int. 2022;2022:5164970.
- Ros PR, Inan I, Erturk SM. Contrast agents in radiology: An overview, in medical imaging contrast agents. Springer International Publishing; 2021:1-4.
- Huynh K, Baghdanian AM, Baghdanian AA, Sun DS, Koli KP, Zagoria RJ, et al. Updated guidelines for intravenous contrast use for CT and MRI. Emerg Radiol. 2020;27(2):115-26.
- Hasebroock KM, Serkova NJ. Toxicity of MRI and CT contrast agents. Expert Opin Drug Metab Toxicol. 2009;5(4):403-16.
- Christiansen C. X-ray contrast media – an overview. Toxicology. 2005;209(2):185-7.
- Heshmatzadeh Behzadi A, Prince MR. Preventing allergic reactions to gadolinium-based contrast agents. Top Magn Reson Imaging. 2016;25(6):275-9.
- Koç MM, Aslan N, Kao AP, Barber AH. Evaluation of X-ray tomography contrast agents: A review of production, protocols, and biological applications. Microsc Res Tech. 2019;82(6):812-48.
- Endrikat J, Michael A, Kolbach R, Lengsfeld P, Vogtlander K. Risk of hypersensitivity reactions to iopromide after intra-arterial versus intravenous administration: A nested case-control analysis of 133,331 patients. Invest Radiol. 2020;55(1):38-44.
- Cademartiri F, de Monye C, Pugliese F, Mollet NR, Runza G, van der Lugt A, et al. High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: Iopromide 370 versus iomeprol 400. Invest Radiol. 2006;41(3):349-53.
- Schönmann C, Brockow K. Adverse reactions during procedures: Hypersensitivity to contrast agents and dyes. Ann Allergy Asthma Immunol. 2020;124(2):156-64.
- Pomara C, Pascale N, Maglietta F, Neri M, Riezzo I, Turillazzi E. Use of contrast media in diagnostic imaging: medico-legal considerations. Radiol Med. 2015;120(9):802-9.
- Dekker HM, Stroomberg GJ, Prokop M. Tackling the increasing contamination of the water supply by iodinated contrast media. Insights Imaging. 2022;13(1):30.
- Spampinato MV, Abid A, Matheus MG. Current radiographic iodinated contrast agents. Magn Reson Imaging Clin N Am. 2017;25(4):697-704.
- Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 2008;36(2):69-74.
- Rosado Ingelmo A, Diaz ID, Moreno RC, Quesado MCM, Garcia-Aviles C, Nunez IG, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-55.
- Lusic H, Grinstaff MW. X-ray-Computed Tomography Contrast Agents. Chem Rev. 2013;113(3):1641-66.
- Lorusso V, Taroni P, Alvino S, Spinazzi A. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol. 2001;36(6):309-16.
- Deray G. Dialysis and iodinated contrast media. Kidney Int. 2006;69:25-9.
- Beckett KR, Moriarity AK, Langer JM. Safe use of contrast media: what the radiologist needs to know. RadioGraphics. 2015;35(6):1738-50.
- Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ. 2006;333(7570):675.
- Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. Int J Angiol. 2013;22(03):149-54.
- Davenport MS, Perazella MA, Yee J, Dillman JR, Fine P, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294(3):660-8.
- Zhang B, Dong Y, Liang L, Lian Z, Liu J, Luo X, et al. The incidence, classification, and management of acute adverse reactions to the low-osmolar iodinated contrast media isovue and ultravist in contrast-enhanced computed tomography scanning. Medicine. 2016;95(12):3170.
- Gharekhanloo F, Torabian S. Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol. 2012;9(2):63-6.
- An J, Jung H, Kwon OY, Kang Y, Lee JK, Won HK, et al. Differences in adverse reactions among iodinated contrast media: Analysis of the KAERS database. J Allergy Clin Immunol Pract. 2019;7(7):2205-11.
- Jost G, Pietsch H, Lengsfeld P, Hütter J, Sieber MA. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination. Invest Radiol. 2010;45(5):255-61.
- Goldberg SN, Abrahams J, Drayer BP, Golding S, Bernardino M, Brunetti J. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography. Invest Radiol. 1994;29 Suppl 1:S76-83.
- Jean‐Marc I, Emmanuelle P, Philippe P, Claire C. Allergy‐like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol. 2005;19(3):263-81.
- Endrikat J, Gerlinger C, Pracz M, Lengsfeld P, Bhatti A, Michel A. Risk of hypersensitivity reactions to iopromide in children and elderly: An analysis of 132,850 patients from 4 observational studies and pharmacovigilance covering >288 million administrations. Invest Radiol. 2022;57(5):318-26.
- Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol. 2008;49(8):902-11.
- Mortelé KJ, Oliva M-R, Ondategue S, Ras PR, Silverman SS. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR. 2005; 184(1):31-4.
- Palkowitsch PK, Bostelmann S, Lengsfeld P. Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol. 2014;55(6): 707-14.
- García M, Aguirre U, Martinez A, Ruiz B, Lertxundi U, Aguirre C. Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department. Br J Radiol. 2014;87(1033):20130511.
- Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, et al. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial. Intern Med J. 2009;39(1):25-31.
- Nie B, Cheng WJ, Li YF, Cao Z, Yang QY, Zhao Y-X, et al. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Catheter Cardiovasc Interv. 2008;72(7):958-65.
- Dong S-J, Gao X-Y, Pei M-X, Luo T, Fan D, Chen Y-L, et al. Effects and mechanism of salvianolic acid B on the injury of human renal tubular epithelial cells induced by iopromide. Front Pharmacol. 2021;21:761908.
- Iordache AM, Docea AO, Buga AM, Mitrut R, Albulescu D, Zlatian O, et al. The incidence of skin lesions in contrast media-induced chemical hypersensitivity. Exp Ther Med. 2019;17(2):1113-24.
- Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: A primer for the non-radiologist. Mayo Clin Proc. 2012;87(4):390-402.
- Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: an update. Curr Probl Diagn Radiol. 2006;35(4):164-9.
- Namasivayam S, Kalra MK, Torres WE, Small WC Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol. 2006;12(5):210-5.
- Matos C, Joaquim J, Pires T. Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal. Drugs Ther Perspectiv. 2017;33:88-94.
- Matos C, Rodrigues L, Joaquim J. Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system. Drug Ther Perspectiv. 2017;33:188-94.
- Matos C, van Hunsel F, Tavares Ribeiro R, Nascimento do ÓD, Raposo JF. Diabetes patient’s pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation. Ther Adv Drug Saf. 2020;11:2042098620953935.
